Opportunity Information: Apply for PA 15 143
Apply for PA 15 143
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "International Research Collaboration on Drug Abuse and Addiction Research (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Mar 17, 2015 and posted on Mar 17, 2015.
- Applicants must submit their applications by May 7, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: Small businesses Others (see text field entitled Additional Information on Eligibility for clarification) County governments For profit organizations other than small businesses Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts State governments City or township governments Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The International Research Collaboration on Drug Abuse and Addiction Research (R21) opportunity (Funding Opportunity Number PA 15-143) is a National Institutes of Health grant announcement from the National Institute on Drug Abuse (NIDA) designed to support early-stage, exploratory research projects that rely on meaningful international collaboration. The central idea is to fund studies in drug abuse and addiction that are stronger, faster, or uniquely possible because key elements of the work occur outside the United States. NIDA is specifically looking for projects that take advantage of special opportunities found in other countries, such as access to distinctive scientific expertise, unique facilities or resources, particular patient or community populations, or environmental and policy conditions that cannot easily be replicated in the U.S. The expectation is that these international advantages will accelerate discovery and produce insights with clear relevance to NIDA's mission.
This announcement uses the NIH R21 mechanism, which is intended for exploratory and developmental research. In practical terms, that means the program is geared toward projects that are still in the conceptual or early testing phase, where investigators are trying innovative approaches, piloting new ideas, or establishing proof-of-concept. Because of that emphasis, the FOA explicitly allows for higher-risk studies, as long as they have the potential to open up a new research direction, generate a breakthrough, or lead to the creation of novel tools and methods, such as new techniques, interventions, models, agents, or analytic approaches that could significantly shape biomedical, behavioral, or clinical research related to substance use and addiction. The announcement also draws a boundary between the R21 and smaller, more limited efforts, noting that projects that are narrow in scope and rely on widely accepted methods in well-established areas may be more appropriate for the R03 small grant mechanism instead.
While applications must align with NIDA's broader mission, the FOA also encourages investigators, where feasible, to address NIDA international scientific priority areas, which can shift year to year. For the fiscal year referenced in the announcement (FY15), examples of priority topics include research on the connections between HIV/AIDS and drug abuse prevention and treatment, including how drug use intersects with HIV risk and outcomes. Another highlighted area is the initiation and treatment of nicotine and tobacco use, with a particular focus on vulnerable groups such as children and adolescents, pregnant women, and individuals with co-morbid disorders. The FOA also calls out interest in the neuroscience of marijuana and cannabinoids, as well as research examining how changes in marijuana laws and policies influence marijuana use, related harms, and broader public health impacts. Even when applicants propose work outside these examples, the main requirement remains that the study addresses drug abuse or addiction questions that matter to NIDA and that the international setting meaningfully strengthens the science.
From an administrative standpoint, this is a discretionary grant in the education and health funding activity category, listed under CFDA 93.279 (Drug Abuse and Addiction Research Programs). The posted and created date for the opportunity was March 17, 2015, with an original and current closing date of May 7, 2018, and an archive date of June 7, 2018, indicating the announcement is no longer active as a live competition. The listed award ceiling is $200,000, and the opportunity does not require cost sharing or matching.
Eligibility is broad and includes many types of U.S. and non-U.S. organizations. Eligible applicants include public and private institutions of higher education, nonprofits with and without 501(c)(3) status, for-profit organizations (including small businesses and other for-profits), state, county, city or township governments, independent school districts, special district governments, public housing authorities, and tribal governments and tribal organizations (including federally recognized tribes and other tribal entities). The FOA also explicitly includes a wide range of special categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, and Asian American Native American Pacific Islander-serving institutions (AANAPISIs), along with faith-based and community-based organizations, eligible federal agencies, U.S. territories or possessions, regional organizations, and importantly, non-domestic entities (foreign organizations). That eligibility structure matches the purpose of the program, which is to stimulate genuine international research collaboration rather than limiting awards to U.S.-only institutions.
The full announcement was made available through the NIH Grants Guide (the linked page in the source is the authoritative document), and NIH provided standard contact support through the NIH Office of Extramural Research webmaster channels for access and technical linking issues.
Frequently Asked Questions (FAQs)
What is this grant opportunity?
This opportunity is the International Research Collaboration on Drug Abuse and Addiction Research (R21), Funding Opportunity Number PA 15-143. It is a National Institutes of Health (NIH) funding announcement from the National Institute on Drug Abuse (NIDA) to support exploratory, early-stage research projects in drug abuse and addiction that depend on meaningful international collaboration.
Which NIH institute is sponsoring this funding opportunity?
The sponsoring NIH institute is the National Institute on Drug Abuse (NIDA).
What is the main purpose of the program?
The program is designed to fund studies in drug abuse and addiction that are stronger, faster, or uniquely possible because critical elements of the research take place outside the United States. Projects are expected to leverage real advantages of conducting the work internationally in ways that accelerate discovery and produce findings relevant to NIDA's mission.
What does "meaningful international collaboration" mean in this FOA?
Based on the FOA description, international collaboration is considered meaningful when key elements of the work occur outside the U.S. and the international setting provides a clear scientific advantage. Examples include access to distinctive expertise, unique facilities or resources, specific patient or community populations, or environmental and policy conditions that cannot easily be replicated in the United States.
What grant mechanism does this announcement use?
This announcement uses the NIH R21 mechanism, which supports exploratory and developmental research.
What types of projects are a good fit for an NIH R21 under this program?
The FOA emphasizes early-stage, conceptual, or proof-of-concept projects. This includes piloting innovative ideas, testing novel approaches, and exploratory work that may be higher risk but could open new research directions or lead to breakthroughs relevant to substance use and addiction research.
Are higher-risk studies allowed?
Yes. The FOA explicitly allows higher-risk studies, as long as they have the potential to generate a breakthrough, open a new research direction, or create novel tools and methods relevant to biomedical, behavioral, or clinical research on substance use and addiction.
What kinds of outputs or innovations does the FOA highlight?
The FOA notes that R21 projects may lead to the creation of novel tools and methods such as new techniques, interventions, models, agents, or analytic approaches that could significantly shape substance use and addiction research.
How is this R21 opportunity different from an R03 small grant?
The FOA draws a boundary by noting that projects that are narrow in scope and rely on widely accepted methods in well-established areas may be more appropriate for the R03 small grant mechanism, rather than this R21 exploratory mechanism.
Do proposed projects need to align with any specific scientific priorities?
Applications must align with NIDA's broader mission. The FOA also encourages investigators, where feasible, to address NIDA international scientific priority areas, which can change from year to year.
What international scientific priority areas are mentioned for the referenced fiscal year?
For FY15 (as referenced in the announcement), example priority topics include: (1) connections between HIV/AIDS and drug abuse prevention and treatment, including intersections of drug use with HIV risk and outcomes; (2) initiation and treatment of nicotine and tobacco use, especially in vulnerable groups such as children and adolescents, pregnant women, and individuals with co-morbid disorders; (3) neuroscience of marijuana and cannabinoids; and (4) research on how changes in marijuana laws and policies influence marijuana use, related harms, and broader public health impacts.
Can an application be competitive if it does not focus on the example priority topics?
Yes. The FOA indicates that even when applicants propose work outside the provided examples, the main requirement is that the study addresses drug abuse or addiction questions that matter to NIDA and that the international setting meaningfully strengthens the science.
What is the award ceiling for this opportunity?
The listed award ceiling is $200,000.
Is cost sharing or matching required?
No. The opportunity states that cost sharing or matching is not required.
What is the CFDA number associated with this program?
The program is listed under CFDA 93.279, Drug Abuse and Addiction Research Programs.
What kind of grant is this from an administrative perspective?
It is described as a discretionary grant in the education and health funding activity category.
When was the opportunity posted and when did it close?
The posted/created date is March 17, 2015. The original and current closing date listed is May 7, 2018, and the archive date is June 7, 2018.
Is this funding opportunity still active?
No. The closing and archive dates indicate the announcement is no longer active as a live competition.
Who is eligible to apply?
Eligibility is broad and includes U.S. and non-U.S. organizations. Eligible applicants include public and private institutions of higher education; nonprofits with and without 501(c)(3) status; for-profit organizations (including small businesses); state, county, city or township governments; independent school districts; special district governments; public housing authorities; and tribal governments and tribal organizations (including federally recognized tribes and other tribal entities).
Are foreign (non-U.S.) organizations eligible to apply?
Yes. The FOA explicitly includes non-domestic entities (foreign organizations) as eligible applicants, consistent with the program goal of supporting international research collaboration.
Are minority-serving institutions and other special categories included in the eligibility list?
Yes. The eligibility language explicitly includes categories such as HBCUs, Hispanic-serving institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian-serving institutions, and Asian American Native American Pacific Islander-serving institutions (AANAPISIs). It also includes faith-based and community-based organizations.
Are federal agencies eligible to apply?
Yes. The eligibility list includes eligible federal agencies.
Are U.S. territories or possessions eligible to apply?
Yes. The eligibility list includes U.S. territories or possessions.
Where can applicants find the authoritative version of the full announcement?
The full announcement was made available through the NIH Grants Guide, which is described as the authoritative document.
Who provides support for access or technical issues related to the announcement?
NIH provided standard contact support through the NIH Office of Extramural Research webmaster channels for access and technical linking issues.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Limited Competition Continuation of the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study (U01)
Previous opportunity: Molecular Imaging of the Lung Phase 2 (R01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 15 143
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 15 143) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition Revisions to Add Phase 2 Clinical Trials Program to Experimental Therapeutics Clinical Trials Network (ETCTN)(UM1) Apply for RFA CA 15 501 Funding Number: RFA CA 15 501 Agency: National Institutes of Health Category: Education Health Funding Amount: $560,000 |
| Cancer Research Education Grants Program Research Experiences (R25) Apply for PAR 15 152 Funding Number: PAR 15 152 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Cancer Research Education Grants Program Courses for Skills Development (R25) Apply for PAR 15 151 Funding Number: PAR 15 151 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Cancer Research Education Grants Program Curriculum or Methods Development (R25) Apply for PAR 15 150 Funding Number: PAR 15 150 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Administrative Supplements to Promote Cancer Prevention and Control Research in Low and Middle Income Countries (Admin Supp) Apply for PAR 15 155 Funding Number: PAR 15 155 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions (R21) Apply for RFA CA 15 009 Funding Number: RFA CA 15 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions (R01) Apply for RFA CA 15 008 Funding Number: RFA CA 15 008 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Regional Medical Libraries for the National Network of Libraries of Medicine (UG4) Apply for RFA LM 15 003 Funding Number: RFA LM 15 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34) Apply for PA 15 177 Funding Number: PA 15 177 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Abuse (R34) Apply for PA 15 250 Funding Number: PA 15 250 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
| Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R01) Apply for PA 15 251 Funding Number: PA 15 251 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R03) Apply for PA 15 252 Funding Number: PA 15 252 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R21) Apply for PA 15 253 Funding Number: PA 15 253 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Development of Measures of Fatigability in Older Adults (R21) Apply for RFA AG 16 013 Funding Number: RFA AG 16 013 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Provocative Questions in Cancer with an Underlying HIV Infection (R21) Apply for RFA CA 15 013 Funding Number: RFA CA 15 013 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Provocative Questions (PQ) Initiative Cancer with an Underlying HIV Infection (R01) Apply for RFA CA 15 012 Funding Number: RFA CA 15 012 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Clinical and Translational Science Award (CTSA) Network Recruitment Innovation Centers (RICs)(U24) Apply for RFA TR 15 004 Funding Number: RFA TR 15 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,000,000 |
| Assay Validation For High Quality Markers For NCI Supported Clinical Trials (Admin Supp) Apply for PA 15 264 Funding Number: PA 15 264 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Martin Delaney Collaboratories for HIV Cure Research (UM1) Apply for RFA AI 15 029 Funding Number: RFA AI 15 029 Agency: National Institutes of Health Category: Education Health Funding Amount: $3,500,000 |
| Oncology Co Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24) Apply for PAR 15 266 Funding Number: PAR 15 266 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 15 143", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.